In a cell proliferation screening assay of NCI-60 cell lines, we found that GNA and its variants exert a high efficacy on multiple cell lines, including NSCLC, and one of the protein targets was the STAT3/JAK signaling pathway19. This evidence concerns the gene STAT3 and non-small cell lung carcinoma.